CD45 antibody (C-Term)
Quick Overview for CD45 antibody (C-Term) (ABIN870386)
Target
See all CD45 (PTPRC) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1277-1292, C-Term
-
Purpose
- Anti-CD45
-
Specificity
- CD45
-
Immunogen
- Peptide derived from C-terminal sequence of human CD45. Antibody recognizes the epitope between Glu1277 - Val1292.
-
Isotype
- IgG
-
-
-
-
Application Notes
- 1:100 - 1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- +2 °C to +8 °C
-
-
- CD45 (PTPRC) (Protein tyrosine Phosphatase, Receptor Type, C (PTPRC))
-
Alternative Name
- CD45
-
Background
- Protein tyrosine phosphatase receptor CD45 is expressed on all leukocytes. Alternate expression is detected in all lymphomas, hairy cell leukemias and acute non-lymphocytic leukemia. This transmembrane protein (type I), originally called leukocyte common antigen, is present on differentiated hematopoietic cells (except erythrocytes and platelets) and highly expressed in hairy cell leukemia, lymphomas, B cell chronic lymphocytic leukemia and acute non-lymphocytic leukemia.
-
UniProt
- P08575
-
Pathways
- TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, BCR Signaling
Target
-